Clinical trials

clinical trials

With our strong foundation in immunology and beta-cell biology, we are uniquely positioned to translate discoveries into therapies that can prevent or delay type 1 diabetes. By conducting clinical trials, we take responsibility for bringing promising ideas from the lab to the people who need them—patients, families, and future generations.

Clinical trials projects

2/2/2024
-
10/18/2028
FrexalimAB in preservation of endogenous insULIN secretion compared to placebo in adUlts and adolescents on top of inSulin therapy (FABULINUS)

Promotors:

Kristina Casteels

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.